PL424901A1 - Superparamagnetic nanoparticle based on iron oxides and its applications in biotechnology and medicine - Google Patents
Superparamagnetic nanoparticle based on iron oxides and its applications in biotechnology and medicineInfo
- Publication number
- PL424901A1 PL424901A1 PL424901A PL42490118A PL424901A1 PL 424901 A1 PL424901 A1 PL 424901A1 PL 424901 A PL424901 A PL 424901A PL 42490118 A PL42490118 A PL 42490118A PL 424901 A1 PL424901 A1 PL 424901A1
- Authority
- PL
- Poland
- Prior art keywords
- iron oxides
- biotechnology
- medicine
- applications
- superparamagnetic nanoparticle
- Prior art date
Links
Abstract
Przedmiotem niniejszego zgłoszenia jest superparamagnetyczna nanocząstka na bazie tlenków żelaza, w której od 1% do 3% trójwartościowych jonów Fe3- obecnych w strukturze krystalograficznej nanocząstki jest zastąpiona radionuklidem z grupy lantanowców, holmem 166Ho. Zgłoszenie dotyczy także zastosowania superparamagnetycznej nanocząstki do rozdzielania i oczyszczaniu komórek, mikroorganizmów takich jak wirusów i biologicznych makrocząsteczek oraz jako lek.The subject of the present application is a superparamagnetic nanoparticle based on iron oxides, in which from 1% to 3% of trivalent Fe3-ions present in the crystallographic structure of the nanoparticle is replaced with a lanthanide radionuclide, holm 166Ho. The application also relates to the use of a superparamagnetic nanoparticle for the separation and purification of cells, microorganisms such as viruses and biological macromolecules, and as a drug.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL424901A PL424901A1 (en) | 2018-03-15 | 2018-03-15 | Superparamagnetic nanoparticle based on iron oxides and its applications in biotechnology and medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL424901A PL424901A1 (en) | 2018-03-15 | 2018-03-15 | Superparamagnetic nanoparticle based on iron oxides and its applications in biotechnology and medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL424901A1 true PL424901A1 (en) | 2019-09-23 |
Family
ID=67979724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL424901A PL424901A1 (en) | 2018-03-15 | 2018-03-15 | Superparamagnetic nanoparticle based on iron oxides and its applications in biotechnology and medicine |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL424901A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4758429A (en) * | 1985-11-04 | 1988-07-19 | Gordon Robert T | Method for the treatment of arthritis and inflammatory joint diseases |
US9196405B2 (en) * | 2012-04-03 | 2015-11-24 | Florida State University Research Foundation, Inc. | Stable iron oxide nanoparticles and method of production |
-
2018
- 2018-03-15 PL PL424901A patent/PL424901A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4758429A (en) * | 1985-11-04 | 1988-07-19 | Gordon Robert T | Method for the treatment of arthritis and inflammatory joint diseases |
US9196405B2 (en) * | 2012-04-03 | 2015-11-24 | Florida State University Research Foundation, Inc. | Stable iron oxide nanoparticles and method of production |
Non-Patent Citations (3)
Title |
---|
I. MUNAWEERA, RADIOTHERAPEUTIC BANDAGE BASED ON ELECTROSPUN POLYACRYLONITRILE CONTAINING HOLMIUM-166 IRON GARNET NANOPARTICLES FOR THE TREATMENT OF SKIN CANCER -ACS APPL. MATER, 2014 * |
K. V. VIMALNATH, FORMULATION, CHARACTERIZATION AND BIOEVALUATION OF HOLMIUM-166 LABELED AGGLOMERATED IRON OXIDE NANOPARTICLES FOR TREATMENT OF ARTHRITIS OF KNEE JOINTS, ELSEVIER, 2017 * |
MI KYUNG YU, DRUG-LOADED SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES FOR COMBINED CANCER IMAGING AND THERAPY IN VIVO, 2008 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501473A1 (en) | Novel proteins specific for pyoverdine and pyochelin | |
MX2017012512A (en) | Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto. | |
UY35377A (en) | 1,3-OXAZIN-2-AMINA COMPOUNDS FUSED WITH PERFLUORATED CYCLOPROPYL AS BETA-SECRETASE INHIBITORS AND METHODS OF USE | |
Gao et al. | Transplanted neural stem cells modulate regulatory T, γδ T cells and corresponding cytokines after intracerebral hemorrhage in rats | |
EA201590890A1 (en) | DERIVATIVES 5-FLUOR-N- (PYRIDIN-2-IL) PYRIDIN-2-AMINE CONTAINING A SULPHOXIMINE GROUP | |
UY36157A (en) | COMPOSITIONS PESTICIDES AND PROCEDURES RELATED TO THE SAME | |
IN2015DN02729A (en) | ||
EA202090880A1 (en) | STAINLESS STEEL | |
CO2017000030A2 (en) | Molecules that have some pesticidal utility and related intermediates, compositions and processes | |
MY168778A (en) | Oligonucleotide chelate complex-polypeptide compositions and methods | |
PH12015502128A1 (en) | Novel dosing regimens of celgosivir for the treatment of dengue | |
Gao et al. | The mechanism of cd8+ t cells for reducing myofibroblasts accumulation during renal fibrosis | |
PL424901A1 (en) | Superparamagnetic nanoparticle based on iron oxides and its applications in biotechnology and medicine | |
TR201905218T4 (en) | USEFUL VITANOLIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES. | |
BR112015006243A2 (en) | fenicol antibacterial agents | |
EA201992804A1 (en) | AMINOGLYCOSIDE DERIVATIVES AND THEIR APPLICATION IN TREATMENT OF GENETIC DISEASES | |
MY186900A (en) | Crystal forms of a 9-aminomethyl substituted tetracycline compound and preparation method therefor | |
CN106266589A (en) | A kind of formula controlling consumptive disease | |
WANG | Effect of Periplaneta americana extract on H125 lung cancer cells | |
Battams et al. | Global Health Diplomacy Briefing: Discussing a Definition of Global Health | |
Ballabeni | The definition of public health-where to shift the focus: prevention or population? | |
PL431336A1 (en) | Lipopeptides, pharmaceutical composition, cosmetic composition, and lipopeptides for use as medicine | |
Minnullina et al. | The hemolytic propertiesof clinical isolates of Morganella morganii | |
Paton | Fit notes aid communication, but vary greatly in how they are used | |
John | Halomonas: An Emerging Pathogen? |